Axella Research is a clinical development venture company offering a unique research model for companies exploring options to further develop their technology for clinical applications and/or regulatory approval through mitigating the financial burden and navigating the regulatory environment. We serve as a strategic partner to assist in expediting clinical research utilizing our SMO/CRO services with both a traditional fee for service model as well as our innovative equity driven model.